Saturday, July 18, 2026 Latest Longevity Experts Prioritize Functional Strength Training Our standards
Health

DRC’s Ebola Outbreak Spreads at Fastest Rate

A Record-Breaking Spread in the DRC
A Record-Breaking Spread in the DRC

The Ebola outbreak in the Democratic Republic of the Congo (DRC) is spreading at its fastest rate on record, with over 2,000 confirmed cases reported since May 2026. While the DRC battles surging infections and active conflict, Uganda has discharged its final patient, beginning a 42-day countdown to be declared virus-free.

A Record-Breaking Spread in the DRC

The current Ebola epidemic in the DRC is expanding faster than any previous outbreak managed by the World Health Organization. While the 2018–2020 outbreak took 10 months to reach 2,000 confirmed cases, the current crisis hit that threshold in just two months. According to the National Institute of Public Health, the death toll has climbed rapidly, with 754 confirmed deaths as of July 14.

A Record-Breaking Spread in the DRC
Photo: AP News

Health officials warn that these figures likely represent only a fraction of the reality. Abcnews, executive director of the WHO’s health emergencies programme, noted that 80 percent of new infections are emerging from unknown chains of transmission. The WHO suggests the true scale of the epidemic could be at least two to four times larger than the official tally, as many patients die in their communities without ever reaching a medical facility.

Conflict and Infrastructure Challenges

The response is severely hampered by a volatile security environment. Much of the outbreak is centered in Ituri, a mineral-rich province where active armed conflict frequently blocks access for aid workers. These conditions have led to operational failures, including the interruption of safe-burial activities in Rwampara and the recent closure of facilities due to labor strikes.

While some staff later agreed to resume work under a 72-hour ultimatum for payment, the unrest highlights the fragility of the response.

Clinical Hurdles and Experimental Treatments

This outbreak involves the rare Bundibugyo strain, which lacks an approved vaccine or standard treatment. The crude case-fatality rate has risen to 37 percent, a statistic the WHO attributes to delays in care rather than increased disease severity; 92 percent of confirmed deaths occurred before patients reached a treatment center.

Ebola outbreak spreads to more provinces in DR Congo • FRANCE 24 English

Researchers have initiated studies on two potential treatments: remdesivir and the antibody MBP134.

Uganda’s Path to Being Virus-Free

In contrast to the surge in the DRC, Uganda discharged its last remaining Ebola patient on Thursday. The patient, a Congolese national, was released from the Mulago National Referral Hospital in Kampala. Uganda has recorded 20 cases since mid-May, 15 of which were imported from the DRC. With no new cases reported since June 22, the country has entered a 42-day observation period. If no further cases emerge, the WHO will declare Uganda free of the virus, a milestone officials credit to well-established protocols for isolation and contact tracing.

The Funding Gap and Future Vigilance

International support remains a critical point of contention. The WHO and the Africa Centres for Disease Control have launched a joint response plan with an ask of US$ 518 million.

Tedros Adhanom Ghebreyesus, WHO Director-General, has emphasized the urgent need for international support to address the outbreak, highlighting the importance of global health security and the critical role of funding in containing the crisis.

=== END ARTICLE ===

Accuracy matters. See something that needs attention? Read our corrections policy or contact the newsroom.

Health Editor

Nora Chen

Nora Chen is the editorial identity for TellingPointy's Health desk, covering medicine, public health, biotechnology, wellbeing, and health policy with reader safety in mind. Chen's desk distinguishes association from causation, early findings from clinical guidance, and population-level evidence from individual advice. It reports benefits alongside risks, avoids miracle language, and makes uncertainty visible so readers can understand the evidence without mistaking journalism for personal medical care.